Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DR26F5N92
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,168
Award facts
- Contract value 100% obligated
- $19,167.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) prefilled syringes with a contract ceiling value of $19,167.69. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and was executed on November 20, 2025, with an ultimate completion date of November 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement across the military healthcare system.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains to support military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The underlying IDC supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers on a global basis, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts potentially involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26F5N92?
SPE2DR26F5N92 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F5N92 worth?
The government has obligated $19,168 on SPE2DR26F5N92.
Is contract SPE2DR26F5N92 an order under another contract?
Yes. SPE2DR26F5N92 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5N92 competed?
The extent of competition for SPE2DR26F5N92 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award